Join
Live feed
·
INSIDERFilingvia Quantisnow
Aardvark Therapeutics Inc. logo

Chief Executive Officer Lee Tien-Li converted options into 41,303 shares and bought $264,672 worth of shares (16,542 units at $16.00), increasing direct ownership by 4% to 1,496,175 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AARD (Aardvark Therapeutics Inc.) and more on Quantisnow.